Firefly Neuroscience, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: Arena Investors Divests Firefly Neuroscience Stake
Arena Investors and its affiliates have reported zero beneficial ownership in Firefly Neuroscience, Inc. common stock as of March 31, 2025.
NASDAQ
SCHEDULE 13G/A: Roxy Capital Corp Amends Stake in Firefly Neuroscience, Inc., Reports 3.65% Beneficial Ownership
Roxy Capital Corp has filed an amended Schedule 13G, disclosing a 3.65% beneficial ownership stake in Firefly Neuroscience, Inc.'s common stock.
NASDAQ
SCHEDULE 13G: Arena Investors Discloses 9.0% Stake in Firefly Neuroscience Following Convertible Note Conversion
Arena Investors and its affiliates have disclosed a 9.0% beneficial ownership stake in Firefly Neuroscience, Inc., acquiring 800,000 shares through the conversion of a convertible promissory note.
NASDAQ
Christopher Finn, Eadwacer Holdings, LLC, and Harleston Capital LLC have jointly filed an amended Schedule 13G, reporting a combined passive beneficial ownership of 4.1% in Firefly Neuroscience, Inc.'s common stock as of December 31, 2024.